NCT06435676View on ClinicalTrials.gov

A Study of Single and Multiple Doses HRS9531 Tablets in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 4, 2024

Primary Completion Date

October 8, 2024

Study Completion Date

October 8, 2024

Conditions
Overweight or Obesity; Type 2 Diabetes
Interventions
DRUG

HRS9531

Single dose escalation of HRS9531 tablets in healthy subjects

DRUG

Placebo

Single dose of placebo in healthy adults

DRUG

HRS9531

Multiple dose escalation of HRS9531 tablets in healthy subjects

DRUG

Placebo

Multiple dose of placebo in healthy adults

Trial Locations (1)

230601

The Second Hospital Of Anhui medical University, Hefei

All Listed Sponsors
lead

Fujian Shengdi Pharmaceutical Co., Ltd.

INDUSTRY

NCT06435676 - A Study of Single and Multiple Doses HRS9531 Tablets in Healthy Subjects | Biotech Hunter | Biotech Hunter